The Vape Cloud Hanging Over the FDA
Summary
FDA Commissioner Dr. Marty McCary resigned amid a leadership shakeup driven by President Trump’s frustration over stalled vaping approvals. McCary’s tenure faced criticism from the pharmaceutical industry and GOP allies for drug rejections and slow action on abortion pill reviews. The vaping controversy, specifically the rejection of flavored e-cigarettes, accelerated his ouster as Trump sought to fulfill campaign promises to the vaping industry. Acting commissioner Kyle Diamantis now leads the agency amid a policy shift allowing unapproved nicotine products to market.
Topics discussed
FDA Commissioner Marty McCary resigns amid controversy
Show intro and sponsor advertisements
Trump's shifting stance on vaping and youth health concerns
Rise of black market vapes and political motivations
Sponsor advertisements
Glass vape application stalled by McCary's caution
Trump's frustration leads to McCary's ouster
New FDA policy allows unapproved nicotine products
Acting commissioner appointed and future FDA direction
Listen ad-free on Castria